Favorite  |  Set Home
BGP-15

BGP-15

Description of:BGP-15(cas:66611-37-8)
BGP-15 is a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin wi...
More>>
Inolitazone (Efatutazone)

Inolitazone (Efatutazone)

Inolitazone (Efatutazone) is an orally bioavailable PAPR-gamma inhibitor with potential antineoplastic activity. Inolitazone binds to and activates pe...
More>>
Atopaxar (E 5555)

Atopaxar (E 5555)

Atopaxar (E-5555) is a potent protease-activated receptor (PAR-1) antagonist targeting the G-coupled receptor and modulating thrombin-platelet-endothe...
More>>
Rucaparib (AG 014699, PF 01367338)

Rucaparib (AG 014699, PF 01367338)

Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM.Rucaparib selectively binds to PARP1 and inhibits PARP1-mediated DNA repa...
More>>
AG 14361

AG 14361

AG 14361 is a PARP-1 inhibitor with Ki < 5 nmol/L. AG14361 is at least 1000-fold more potent than the benzamides. The IC50 for AG14361 is 29 nM in ...
More>>
ABT 888 (Veliparib)

ABT 888 (Veliparib)

Veliparib (ABT 888) is a poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with Kis of 5.2 and 2.9 nM respectively. With no antiproliferative eff...
More>>
Olaparib (AZD2281)

Olaparib (AZD2281)

Olaparib (AZD 2281) acts as an inhibitor of the enzyme Poly ADP ribose polymerase (PARP) and is one of the first PARP inhibitors. Patients with BRCA1/...
More>>
Iniparib (BSI-201)

Iniparib (BSI-201)

Iniparib (BSI-201) is a potent PARP1 inhibitor with strong anti-neoplastic effect. BSI-201 covalently binds and inhibits PARP-1. When given as a singl...
More>>
Total: 8 Page: 1 / 1 First ←Previous Next→ End